EDGAR Filing Documents for 0001420720-22-000018

Form 8-K - Current report:

SEC Accession No. 0001420720-22-000018

Filing Date

2022-05-12

Accepted

2022-05-12 16:00:15

Documents

Period of Report

2022-05-09

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	ibio-20220509x8k.htm iXBRL	8-K	59831
2	EX-3.1	ibio-20220509xex3d1.htm	EX-3.1	73062
3	EX-10.1	ibio-20220509xex10d1.htm	EX-10.1	104216
4	EX-10.2	ibio-20220509xex10d2.htm	EX-10.2	13325
	Complete submission text file	0001420720-22-000018.txt		406574

Data Files

Seq	Description	Document	Type	Size
5	EX-101.SCH	ibio-20220509.xsd	EX-101.SCH	2767
6	EX-101.LAB	ibio-20220509_lab.xml	EX-101.LAB	14057
7	EX-101.PRE	ibio-20220509_pre.xml	EX-101.PRE	10578
9	EXTRACTED XBRL INSTANCE DOCUMENT	ibio-20220509x8k_htm.xml	XML	4760

Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737

Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650

iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)